Total Payments
$868.74
2024 Payments
$174.41
Companies
20
Transactions
48
Medicare Patients
1,296
Medicare Billing
$64,841
Payment Breakdown by Category
Food & Beverage$868.74 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $868.74 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $324.01 | 17 | $0 (2024) |
| Grifols USA, LLC | $102.97 | 5 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $52.42 | 2 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $41.10 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $39.68 | 2 | $0 (2024) |
| Eisai Inc. | $36.58 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $33.10 | 2 | $0 (2022) |
| Mylan Specialty L.P. | $31.13 | 2 | $0 (2022) |
| Novo Nordisk Inc | $30.63 | 2 | $0 (2022) |
| Lilly USA, LLC | $23.53 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $174.41 | 9 | ABBVIE INC. ($43.78) |
| 2023 | $66.99 | 3 | Grifols USA, LLC ($46.27) |
| 2022 | $217.90 | 13 | ABBVIE INC. ($50.96) |
| 2021 | $409.44 | 23 | AbbVie Inc. ($229.27) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Endocrinology | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Pulmonology | ||||||
| 07/21/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Pulmonology | ||||||
| 06/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Biological | ||||||
| 11/02/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Pulmonology | ||||||
| 07/21/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ALLERGY | ||||||
| 07/14/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Oncology | ||||||
| 06/28/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Gastroenterology | ||||||
| 04/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: PRIMARY CARE | ||||||
| 04/06/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/30/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Pulmonology | ||||||
| 03/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiology | ||||||
| 01/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 269 | 368 | $41,165 | $13,187 |
| 2022 | 10 | 353 | 630 | $58,124 | $19,737 |
| 2021 | 11 | 354 | 596 | $55,177 | $19,117 |
| 2020 | 9 | 320 | 485 | $45,557 | $12,800 |
Total Patients
1,296
Total Services
2,079
Medicare Billing
$64,841
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 81 | $15,957 | $5,632 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 89 | $12,905 | $4,001 | 31.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 30 | 31 | $3,875 | $1,559 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $5,488 | $1,520 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 25 | $275.00 | $210.00 | 76.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 26 | $1,337 | $170.62 | 12.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 36 | $288.00 | $77.45 | 26.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 52 | $1,040 | $16.24 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 103 | $20,341 | $7,472 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 99 | $13,770 | $5,018 | 36.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 42 | 45 | $5,625 | $2,276 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $3,724 | $1,465 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $4,508 | $1,365 | 30.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 14 | 14 | $2,562 | $1,327 | 51.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 61 | $3,130 | $536.14 | 17.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 36 | 51 | $402.00 | $111.20 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 32 | $360.00 | $94.65 | 26.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 19 | 188 | $3,702 | $73.02 | 2.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 104 | $20,488 | $7,886 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 94 | $12,408 | $4,943 | 39.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 32 | 33 | $4,125 | $1,693 | 41.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 14 | $3,724 | $1,677 | 45.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $4,508 | $1,358 | 30.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 24 | 66 | $3,394 | $570.70 | 16.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $2,025 | $523.68 | 25.9% |
About Bryce Campbell
Bryce Campbell is a Family healthcare provider based in Rexburg, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1023417037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bryce Campbell has received a total of $868.74 in payments from pharmaceutical and medical device companies, with $174.41 received in 2024. These payments were reported across 48 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($868.74).
As a Medicare-enrolled provider, Campbell has provided services to 1,296 Medicare beneficiaries, totaling 2,079 services with total Medicare billing of $64,841. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Rexburg, ID
- Active Since 08/14/2014
- Last Updated 08/14/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023417037
Products in Payments
- UBRELVY (Drug) $273.27
- Prolastin-C Liquid (Biological) $102.97
- ZENPEP (Drug) $52.42
- VRAYLAR (Drug) $50.74
- FANAPT (Drug) $41.10
- REXULTI (Drug) $39.68
- Dayvigo (Drug) $36.58
- IMBRUVICA (Drug) $33.10
- Yupelri (Drug) $31.13
- PALFORZIA (Biological) $22.55
- Veozah (Drug) $20.72
- Rybelsus (Drug) $18.68
- Azstarys (Drug) $16.90
- Dexcom G6 Transmitter (Medical Supply) $16.68
- TRINTELLIX (Drug) $16.27
- XIFAXAN (Drug) $12.92
- UPTRAVI (Drug) $12.81
- EMGALITY (Drug) $11.97
- RYBELSUS (Drug) $11.95
- GENERAL PAIN MANAGEMENT (Device) $11.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Rexburg
Rosemary Brown, Fnp-C, FNP-C
Family — Payments: $4,964
Family $4,964
Rachelle Jones, F.n.p.-C, F.N.P.-C
Family — Payments: $2,407
Family $2,407
Beyron Zecher, Fnp-C, FNP-C
Family — Payments: $1,867
Family $1,867
Fay Ashment, Appn-Np, APPN-NP
Family — Payments: $1,859
Family $1,859
Analee Fish, Fnp, FNP
Family — Payments: $1,762
Family $1,762
Angela Peterson, Fnp-C, FNP-C
Family — Payments: $1,679
Family $1,679